Loss of heterozygosity for the NF2 gene in retinal and optic nerve lesions of patients with neurofibromatosis 2.
Individuals affected with the neurofibromatosis 2 (NF2) cancer predisposition syndrome develop specific ocular lesions. To determine whether these lesions result from altered NF2 gene expression, microdissection and PCR were used to investigate 40 ocular lesions from seven eyes of four NF2 patients for LOH, with markers that flank the NF2 gene on chromosome 22q. NF2 protein (merlin) expression was also evaluated in these lesions, using immunohistochemistry. Retinal hamartoma was observed in all seven eyes, including one with combined pigment epithelial and retinal hamartoma (CPERH). Retinal tufts were present in four eyes (three patients), retinal dysplasia in two eyes (two patients), optic nerve neurofibroma in one eye, iris naevoid hyperplasia in two eyes (two patients) and pseudophakia in all eyes. Markers were informative in three patients (six eyes from three unrelated families). One patient was non-informative due to prolonged decalcification. All retinal and optic nerve, but not iris lesions, demonstrated consistent LOH for the NF2 gene. Merlin was not expressed in the retina, optic nerve, or iris lesions. These results suggest that inactivation of the NF2 gene is associated with the formation of a variety of retinal and optic nerve lesions in NF2 patients.
Chan
Chi-Chao
CC
National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. ccc@helix.nih.gov
Koch
Christian A
CA
Kaiser-Kupfer
Muriel I
MI
Parry
Dilys M
DM
Gutmann
David H
DH
Zhuang
Zhengping
Z
Vortmeyer
Alexander O
AO
D000293:Adolescent; D000328:Adult; D000368:Aged; D002892:Chromosomes, Human, Pair 22 / Q000235:genetics; D016515:Genes, Neurofibromatosis 2; D006222:Hamartoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D006801:Humans; D019656:Loss of Heterozygosity; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000378:metabolism; D016518:Neurofibromatosis 2 / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D025581:Neurofibromin 2 / Q000378:metabolism; D019574:Optic Nerve Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D012164:Retinal Diseases / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D015792:Retinal Dysplasia / Q000235:genetics / Q000378:metabolism / Q000473:pathology
D009363:Neoplasm Proteins; D025581:Neurofibromin 2